Malinauskas T, Moore G, Rudolf A, Eggington H, Belnoue-Davis H, El Omari K
Nat Commun. 2024; 15(1):4976.
PMID: 38862520
PMC: 11167000.
DOI: 10.1038/s41467-024-49065-8.
Li J, Liang X, Wang X, Yang P, Jian X, Fu L
JOR Spine. 2024; 7(1):e1302.
PMID: 38222807
PMC: 10782059.
DOI: 10.1002/jsp2.1302.
Gipson G, Nolan K, Kattamuri C, Kenny A, Agricola Z, Edwards N
BMC Biol. 2023; 21(1):16.
PMID: 36726183
PMC: 9893541.
DOI: 10.1186/s12915-023-01522-4.
Howard J, Hart K, Thompson T
Front Endocrinol (Lausanne). 2022; 13:927824.
PMID: 35813657
PMC: 9256959.
DOI: 10.3389/fendo.2022.927824.
Kulikauskas M, X S, Bautch V
Cell Mol Life Sci. 2022; 79(2):77.
PMID: 35044529
PMC: 8770421.
DOI: 10.1007/s00018-021-04033-z.
Structures of activin ligand traps using natural sets of type I and type II TGFβ receptors.
Goebel E, Kattamuri C, Gipson G, Krishnan L, Chavez M, Czepnik M
iScience. 2022; 25(1):103590.
PMID: 35005539
PMC: 8718839.
DOI: 10.1016/j.isci.2021.103590.
Heterodimer-heterotetramer formation mediates enhanced sensor activity in a biophysical model for BMP signaling.
Karim M, Madamanchi A, Dutko J, Mullins M, Umulis D
PLoS Comput Biol. 2021; 17(9):e1009422.
PMID: 34591841
PMC: 8509922.
DOI: 10.1371/journal.pcbi.1009422.
Structural perspective of BMP ligands and signaling.
Gipson G, Goebel E, Hart K, Kappes E, Kattamuri C, McCoy J
Bone. 2020; 140:115549.
PMID: 32730927
PMC: 7502536.
DOI: 10.1016/j.bone.2020.115549.
Repulsive guidance molecules lock growth differentiation factor 5 in an inhibitory complex.
Malinauskas T, Peer T, Bishop B, Mueller T, Siebold C
Proc Natl Acad Sci U S A. 2020; 117(27):15620-15631.
PMID: 32576689
PMC: 7354924.
DOI: 10.1073/pnas.2000561117.
A variant of human growth differentiation factor-9 that improves oocyte developmental competence.
Stocker W, Walton K, Richani D, Chan K, Beilby K, Finger B
J Biol Chem. 2020; 295(23):7981-7991.
PMID: 32350111
PMC: 7278348.
DOI: 10.1074/jbc.RA120.013050.
Molecular basis of ALK1-mediated signalling by BMP9/BMP10 and their prodomain-bound forms.
Salmon R, Guo J, Wood J, Tong Z, Beech J, Lawera A
Nat Commun. 2020; 11(1):1621.
PMID: 32238803
PMC: 7113306.
DOI: 10.1038/s41467-020-15425-3.
Specification of BMP Signaling.
Nickel J, Mueller T
Cells. 2019; 8(12).
PMID: 31817503
PMC: 6953019.
DOI: 10.3390/cells8121579.
Structural biology of the TGFβ family.
Goebel E, Hart K, McCoy J, Thompson T
Exp Biol Med (Maywood). 2019; 244(17):1530-1546.
PMID: 31594405
PMC: 6920667.
DOI: 10.1177/1535370219880894.
In Vitro Release of Bioactive Bone Morphogenetic Proteins (GDF5, BB-1, and BMP-2) from a PLGA Fiber-Reinforced, Brushite-Forming Calcium Phosphate Cement.
Gunnella F, Kunisch E, Horbert V, Maenz S, Bossert J, Jandt K
Pharmaceutics. 2019; 11(9).
PMID: 31484306
PMC: 6781330.
DOI: 10.3390/pharmaceutics11090455.
A Novel Mutation in a Family with Multiple Synostoses Syndrome without Hearing Loss.
Berentsen R, Haukanes B, Juliusson P, Rosendahl K, Houge G
Mol Syndromol. 2019; 9(5):228-234.
PMID: 30733656
PMC: 6362854.
DOI: 10.1159/000492418.
Structural Biology and Evolution of the TGF-β Family.
Hinck A, Mueller T, Springer T
Cold Spring Harb Perspect Biol. 2016; 8(12).
PMID: 27638177
PMC: 5131774.
DOI: 10.1101/cshperspect.a022103.
Beyond CDR-grafting: Structure-guided humanization of framework and CDR regions of an anti-myostatin antibody.
Apgar J, Mader M, Agostinelli R, Benard S, Bialek P, Johnson M
MAbs. 2016; 8(7):1302-1318.
PMID: 27625211
PMC: 5058614.
DOI: 10.1080/19420862.2016.1215786.
Structural and Dynamic Characterization of the C313Y Mutation in Myostatin Dimeric Protein, Responsible for the "Double Muscle" Phenotype in Piedmontese Cattle.
Bongiorni S, Valentini A, Chillemi G
Front Genet. 2016; 7:14.
PMID: 26904102
PMC: 4749705.
DOI: 10.3389/fgene.2016.00014.
GDF-5 can act as a context-dependent BMP-2 antagonist.
Klammert U, Mueller T, Hellmann T, Wuerzler K, Kotzsch A, Schliermann A
BMC Biol. 2015; 13:77.
PMID: 26385096
PMC: 4575486.
DOI: 10.1186/s12915-015-0183-8.
The Inhibitory Core of the Myostatin Prodomain: Its Interaction with Both Type I and II Membrane Receptors, and Potential to Treat Muscle Atrophy.
Ohsawa Y, Takayama K, Nishimatsu S, Okada T, Fujino M, Fukai Y
PLoS One. 2015; 10(7):e0133713.
PMID: 26226340
PMC: 4520684.
DOI: 10.1371/journal.pone.0133713.